adenosine
Adenosine Injection, USP
Approved
Approval ID
d2d06ee6-c89f-49f7-9e2c-46d33ce877a9
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Apr 20, 2022
Manufacturers
FDA
Mylan Institutional LLC
DUNS: 790384502
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
adenosine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code67457-855
Application NumberANDA078686
Product Classification
M
Marketing Category
C73584
G
Generic Name
adenosine
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateApril 20, 2022
FDA Product Classification
INGREDIENTS (3)
sodium chlorideInactive
Code: 451W47IQ8X
Classification: IACT
adenosineActive
Quantity: 3 mg in 1 mL
Code: K72T3FS567
Classification: ACTIB
waterInactive
Code: 059QF0KO0R
Classification: IACT
adenosine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code67457-854
Application NumberANDA078686
Product Classification
M
Marketing Category
C73584
G
Generic Name
adenosine
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateApril 20, 2022
FDA Product Classification
INGREDIENTS (3)
adenosineActive
Quantity: 3 mg in 1 mL
Code: K72T3FS567
Classification: ACTIB
sodium chlorideInactive
Code: 451W47IQ8X
Classification: IACT
waterInactive
Code: 059QF0KO0R
Classification: IACT